This article has been updated to include comments from a conference call and a stock quote.
 
NEW YORK (GenomeWeb News) – Genomic Health said today that sales for its Oncotype Dx breast cancer assay rose 78 percent for the first quarter ended March 31, and the firm shaved 4.3 percent off of its net loss year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.